US health regulator authorizes Pfizer's Covid pill as Omicron surges
Paxlovid, which comprises two types of tablet, was granted an emergency use authorization by the Food and Drug Administration (FDA) after a clinical trial showed it to reduce the risk of hospitalizations and deaths among at-risk people by 88 percent.
PREMIUM World
The US Food and Drug Administration (FDA) on December 22, 2021, authorized a Pfizer's Covid pill for high-risk people aged 12. AFP PHOTO - Pfizer
By NewVision Reporter
Journalists @NewVision
The United States on Wednesday authorized Pfizer's anti-Covid pill for high-risk people aged 12 and up, as a surge of cases driven by the highly infectious Omicron variant threatened holiday